Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01096446 · ClinicalTrials.gov registry record · NA
Intravenous Fat Emulsions and Premature Infants
A NA study, sponsored by OSF Healthcare System.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT01096446 is a NA study that was terminated before completion, run by OSF Healthcare System. The registered enrollment target is 19 participants.
The verdict
NCT01096446, a NA study, was terminated before completion, sponsored by OSF Healthcare System.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to study the tolerances of Extremely Low Birthweight Infants who are born at less than 750 grams who are started at a higher infusion rate of intravenous lipid emulsions (2 gm/kg/day). These infants will be compared with a control group who are at the standard lipid emulsion infusion rate (0.5 gm/kg/day). hypothesis: A. Objectives of this project. Null Hypothesis: There will not be a significant difference for Extremely Low Birth Weight Infants (ELBW) \<750 grams being able to tolerate a higher infusion rate of Intravenous Fat Emulsions (IVFE) within the first days of life (days 1-7) as evidenced by maintenance of a serum triglyceride level of 200 mg/dl or less. Alternative Hypothesis: There will be a significant difference (p\<0.05) for Extremely Low Birth Weight Infants (ELBW) \<750 grams being able to tolerate a higher infusion rate of Intravenous Fat Emulsions (IVFE) within the first days of life (days 1-7) as evidenced by maintenance of a serum triglyceride level of 200 mg/dl or less.
Interventions
- DRUG Intravenous Fat Emulsions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01096446
The ClinicalTrials.gov registry entry for NCT01096446 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OSF Healthcare System, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intravenous Fat Emulsions is the first listed.
NCT01096446 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01096446 about?
NCT01096446 is a clinical study titled "Intravenous Fat Emulsions and Premature Infants". The purpose of this study is to study the tolerances of Extremely Low Birthweight Infants who are born at less than 750 grams who are started at a higher infusion rate of intravenous lipid emulsions (2 gm/kg/day). These infants will be compared with a control group who are at the standard lipid emul...
What is the current status of trial NCT01096446?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2008-04. Estimated completion is 2010-07.
What interventions are being tested in trial NCT01096446?
The interventions under investigation include: Intravenous Fat Emulsions (DRUG).
Who is sponsoring clinical trial NCT01096446?
This trial is sponsored by OSF Healthcare System, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.